Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IITerminatedD-1876-2019

Drug recall · October 2, 2019

Nucala (mepolizumab) Injection recall

Why: Temperature Abuse; Product stored and shipped outside of labeled storage requirements.

Class II: could cause temporary or reversible health problems; serious harm is remote.

The recall

Product

Nucala (mepolizumab) Injection, 100 mg/mL Prefilled Syringe, Single-Dose, For subcutaneous use only, Rx Only, Manufactured by GlaxoSmithKline LLC, Philadelphia, PA 19112, Distributed by GlaxoSmithKline, Research Triangle Park, NC 27709, NDC 0173-0892-42.

Lots / codes

Lot #: S25X, Exp. 03/31/21

Quantity
38 syringes
Company
Cardinal Health dba Specialty Pharmaceutical Services, La Vergne, TN
Distribution
Nationwide in the U.S.
Initiated
September 6, 2019 · Voluntary: Firm initiated
Classified
September 20, 2019
Reported
October 2, 2019
Ended
October 8, 2020
How notified
Letter

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.